178 related articles for article (PubMed ID: 9066621)
21. Effect of timing of surgery during the menstrual cycle of premenopausal breast cancer patients.
Jäger W; Sauerbrei W
Breast Cancer Res Treat; 1995 Jun; 34(3):279-87. PubMed ID: 7579492
[TBL] [Abstract][Full Text] [Related]
22. Timing of breast cancer surgery within the menstrual cycle: tumor proliferative activity, receptor status and short-term clinical outcome.
Mangia A; De Lena M; Barletta A; Marzullo F; Attolico M; Stea B; Petroni S; Labriola A; Cellamare G; Digiesi G; Altieri R; Schittulli F; Paradiso A
J Exp Clin Cancer Res; 1998 Sep; 17(3):317-23. PubMed ID: 9894769
[TBL] [Abstract][Full Text] [Related]
23. [Menstrual cycle and surgery of breast cancer. Point of time for the surgery of primary breast cancer in connection with menstrual cycle is without prognostic significance].
Kroman NT; Højgaard AD; Andersen KW; Graversen HP; Afzelius P; Lokdam AV; Juul C; Hoffmann J; Bentzon N; Mouridsen HT
Ugeskr Laeger; 1995 Oct; 157(43):5989-93. PubMed ID: 7483079
[TBL] [Abstract][Full Text] [Related]
24. Does the timing of surgery for breast cancer in relation to the menstrual cycle or geomagnetic activity affect prognoses of premenopausal patients?
Takeda Y; Yanagie H; Yoshizaki I; Eriguchi M
Biomed Pharmacother; 2003 Oct; 57 Suppl 1():96s-103s. PubMed ID: 14572684
[TBL] [Abstract][Full Text] [Related]
25. Influence of timing of initiation of adjuvant chemotherapy over survival in breast cancer: a negative outcome study by the Spanish Breast Cancer Research Group (GEICAM).
Jara Sánchez C; Ruiz A; Martín M; Antón A; Munárriz B; Plazaola A; Schneider J; Martínez del Prado P; Alba E; Fernández-Aramburo A
Breast Cancer Res Treat; 2007 Jan; 101(2):215-23. PubMed ID: 16823507
[TBL] [Abstract][Full Text] [Related]
26. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
27. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
Tworoger SS; Sluss P; Hankinson SE
Cancer Res; 2006 Feb; 66(4):2476-82. PubMed ID: 16489055
[TBL] [Abstract][Full Text] [Related]
28. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
Fodor J; Polgár C; Major T; Németh G
Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
[TBL] [Abstract][Full Text] [Related]
29. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
[TBL] [Abstract][Full Text] [Related]
30. Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.
Benchalal M; Le Prisé E; de Lafontan B; Berton-Rigaud D; Belkacemi Y; Romestaing P; Peignaux K; Courdi A; Monnier A; Montcuquet P; Goudier MJ; Marchal C; Chollet P; Abadie-Lacourtoisie S; Datchary J; Veyret C; Kerbrat P
Cancer; 2005 Jul; 104(2):240-50. PubMed ID: 15948160
[TBL] [Abstract][Full Text] [Related]
31. Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF.
Poikonen P; Saarto T; Lundin J; Joensuu H; Blomqvist C
Br J Cancer; 1999 Aug; 80(11):1763-6. PubMed ID: 10468293
[TBL] [Abstract][Full Text] [Related]
32. The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers.
Huang CS; Kuo SH; Lien HC; Yang SY; You SL; Shen CY; Lin CH; Lu YS; Chang KJ
Oncologist; 2008 Jul; 13(7):751-60. PubMed ID: 18614591
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: indirect comparison of dose and schedule in DBCG trials 77, 82, and 89.
Ejlertsen B; Mouridsen HT; Jensen MB
Acta Oncol; 2008; 47(4):662-71. PubMed ID: 18465334
[TBL] [Abstract][Full Text] [Related]
34. The hormonal milieu and prognosis in operable breast cancer.
Fentiman IS; Gregory WM
Cancer Surv; 1993; 18():149-63. PubMed ID: 8012995
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy timing in 4,820 patients with breast cancer: university of florence experience.
Livi L; Borghesi S; Saieva C; Meattini I; Rampini A; Petrucci A; Detti B; Bruni A; Paiar F; Mangoni M; Marrazzo L; Agresti B; Cataliotti L; Bianchi S; Biti G
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):365-9. PubMed ID: 18715726
[TBL] [Abstract][Full Text] [Related]
36. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
37. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
38. Blood hemoglobin level and treatment outcome of early breast cancer.
Henke M; Sindlinger F; Ikenberg H; Gerds T; Schumacher M
Strahlenther Onkol; 2004 Jan; 180(1):45-51. PubMed ID: 14704844
[TBL] [Abstract][Full Text] [Related]
39. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
40. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
